Announcement, Our Impact, Research Update | 05.19.21 PICI Makes Progress in Toughest Tumor Types with Pancreatic Cancer Combo, Immune Activity in Cold Tumors
Partner Highlight | 05.13.21 Empowering Pancreatic Cancer Patients and Delivering Innovative Immunotherapies: 1440 Foundation
Announcement, Our Impact, Research Update | 04.13.21 Five Years of Transforming Cancer Immunotherapy Research, Five Promises Kept
Announcement, Our Impact, Research Update | 04.10.21 New CAR-T Approach Could Overcome Resistance, Avoid Relapse in Some Cancer Patients
Press Release | 03.03.21 Funding the Future of Cancer Research: The Parker Institute for Cancer Immunotherapy Awards Nearly $3 Million to Six Early Career Researchers
Cancer Research Heroes | 02.24.21 Improving Conventional Wisdom: From CAR-T Therapy to Diversity in STEM, Avery Posey Has Big Ideas
Press Release | 02.16.21 Ute Dugan Joins the Parker Institute for Cancer Immunotherapy as Senior Vice President of Clinical Research
Partner Highlight | 01.19.21 Seeking Solutions for Deadly Brain Tumors: Alliance for Cancer Gene Therapy